J.P. Marvel Investment Advisors LLC Sells 1,095 Shares of Centene Co. (NYSE:CNC)

J.P. Marvel Investment Advisors LLC reduced its holdings in Centene Co. (NYSE:CNC) by 2.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 44,735 shares of the company’s stock after selling 1,095 shares during the quarter. J.P. Marvel Investment Advisors LLC’s holdings in Centene were worth $3,368,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. EP Wealth Advisors LLC increased its position in Centene by 1.0% during the 1st quarter. EP Wealth Advisors LLC now owns 13,604 shares of the company’s stock valued at $1,068,000 after purchasing an additional 133 shares during the period. WR Wealth Planners LLC raised its stake in Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after buying an additional 137 shares in the last quarter. Whittier Trust Co. lifted its holdings in Centene by 10.0% in the second quarter. Whittier Trust Co. now owns 1,562 shares of the company’s stock worth $104,000 after buying an additional 142 shares during the period. Mount Yale Investment Advisors LLC boosted its position in Centene by 2.1% during the 3rd quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company’s stock valued at $608,000 after acquiring an additional 167 shares in the last quarter. Finally, Bleakley Financial Group LLC grew its holdings in shares of Centene by 2.4% during the 1st quarter. Bleakley Financial Group LLC now owns 7,287 shares of the company’s stock worth $572,000 after acquiring an additional 173 shares during the period. 93.63% of the stock is owned by hedge funds and other institutional investors.

Centene Stock Down 0.1 %

Centene stock opened at $62.52 on Friday. The firm has a market cap of $31.56 billion, a price-to-earnings ratio of 10.85, a PEG ratio of 0.88 and a beta of 0.49. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. Centene Co. has a 12 month low of $59.77 and a 12 month high of $81.42. The stock has a fifty day simple moving average of $70.40 and a two-hundred day simple moving average of $71.75.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CNC. TD Cowen lifted their price target on Centene from $80.00 to $89.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Cantor Fitzgerald restated an “overweight” rating and set a $90.00 target price on shares of Centene in a report on Tuesday, October 1st. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 28th. Jefferies Financial Group cut shares of Centene from a “buy” rating to a “hold” rating and cut their price objective for the stock from $83.00 to $69.00 in a report on Wednesday, July 24th. Finally, Oppenheimer lowered their target price on shares of Centene from $110.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, July 29th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $83.92.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.